80MG ATORVASTATIN THERAPY IN PATIENTS WITH ST ELEVATION MYOCARDIAL INFARCTION TREATED WITH PRIMARY PTCA - CARDIOTA80-2009

• Conditions: ST elevation Myocardial Infarct; MedDRA version: 9.1Level: LLTClassification code 10064346Term: STEMI

• Registration Number: EUCTR2009-012120-89-IT
• Lead Sponsor: AZIENDA OSPEDALIERA SPEDALI CIVILI DI BRESCIA

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2009-05-20
• Last Update Posted: 3 April 2012

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Age 20 - 75 years
ST elevation myocardial infarction
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Non ST elevation infarct
Unstable Angina
Heart Shock
Intollerance statine therapy

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: EVALUATION OF EARLY INTENSIVE STATINE TREATMENT ON PATIENTS UNDERGOING PRIMARY PTCA WITH ST ELEVATION MYOCARDIAL INFARCTION;Secondary Objective: INFLAMMATORY MARKERS EVALUATION;Primary end point(s): Recurrence of cardiovascular events (Myocardial infarction fatal - non fatal, stroke, reospedalization for unstable angina, arterial revascularization)